Aviva PLC Zai Lab LTD Transaction History

Aviva PLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$22.97 - $30.58 $58,803 - $78,284	2,560 Added 4.51%	59,330 $1.62 Million
Q3 2023 Nov 13, 2023	BUY	$22.72 - $31.49 $31,808 - $44,086	1,400 Added 2.53%	56,770 $1.38 Million
Q2 2023 Aug 10, 2023	BUY	$25.3 - $39.67 $45,540 - $71,406	1,800 Added 3.36%	55,370 $1.54 Million
Q1 2023 May 12, 2023	BUY	$30.21 - $48.1 $45,315 - $72,150	1,500 Added 2.88%	53,570 $1.78 Million
Q4 2022 Feb 09, 2023	BUY	$22.28 - $38.71 $106,944 - $185,808	4,800 Added 10.15%	52,070 $1.6 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $85,500 - $129,225	2,500 Added 5.58%	47,270 $1.62 Million
Q2 2022 Aug 04, 2022	BUY	$23.14 - $49.68 $205,946 - $442,152	8,900 Added 24.81%	44,770 $1.55 Million
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $11,108 - $25,760	400 Added 1.13%	35,870 $1.58 Million
Q4 2021 Feb 10, 2022	BUY	$54.9 - $105.21 $450,180 - $862,722	8,200 Added 30.07%	35,470 $2.23 Million
Q3 2021 Nov 12, 2021	BUY	$105.0 - $178.37 $514,500 - $874,013	4,900 Added 21.9%	27,270 $2.87 Million
Q2 2021 Aug 10, 2021	BUY	$125.11 - $180.0 $75,066 - $108,000	600 Added 2.76%	22,370 $3.96 Million
Q1 2021 May 13, 2021	SELL	$126.27 - $191.71 $63,135 - $95,855	-500 Reduced 2.25%	21,770 $2.91 Million
Q4 2020 Feb 10, 2021	BUY	$81.94 - $135.34 $376,924 - $622,564	4,600 Added 26.03%	22,270 $3.01 Million
Q2 2020 Aug 13, 2020	BUY	$48.82 - $82.53 $229,454 - $387,891	4,700 Added 36.24%	17,670 $1.45 Million
Q1 2020 May 14, 2020	BUY	$39.1 - $62.9 $507,127 - $815,813	12,970 New	12,970 $668,000

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.59B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

Stay updated on Aviva PLC with notifications on news.